In category 4 (individual contributions), which contains the contributions that the software was unable to classify into the previous categories, the word ‘Femama’ obtained the highest score and was related to the technical report published by Femama on Trastuzumab for HER2-positive breast cancer. Here, ERBB2 is linked to breast cancer.